Metabolic Activity Assessment by 18F‐Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID‐19 Vaccination

Walid Shalata; Daniel Levin; Janna Fridman; Victoria Makarov; Muhammed Iraqi; Mitchell Golosky; Keren Rouvinov; Waleed Kian; Alexander Yakobson

doi:10.3390/curroncol29020084

Metabolic Activity Assessment by 18F‐Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID‐19 Vaccination

Walid Shalata, Daniel Levin, Janna Fridman, Victoria Makarov, Muhammed Iraqi, Mitchell Golosky, Keren Rouvinov, Waleed Kian, Alexander Yakobson

The Shraga Segal Department of Microbiology and Immunology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

In the following report, we describe 11 patients with various diagnoses and different treatment statuses (newly diagnosed, receiving treatment, or follow‐up) of oncological diseases (breast, lymphoma, melanoma, and head and neck cancers). The patients underwent PET‐CT for disease staging or follow‐up and it was noted that all patients had areas of hypermetabolic uptake in the axillary lymph‐nodes of the ipsilateral upper extremity where the Pfizer‐BioNTech coronavirus (COVID‐19) vaccine was administered. Following further investigations, including an ultrasound (US), biopsies and an examination of medical records, it was concluded that these findings were the result of the vaccination and not a progression of pre‐existing disease.

Original language	English
Pages (from-to)	989-1000
Number of pages	12
Journal	Current Oncology
Volume	29
Issue number	2
DOIs	https://doi.org/10.3390/curroncol29020084
State	Published - 1 Feb 2022

Keywords

COVID‐19
Coronavirus
Hypermetabolic uptake
Oncology
PET‐CT
Vaccine

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/curroncol29020084

Cite this

@article{239395da8f7a4b93829ab493ec4d7422,

title = "Metabolic Activity Assessment by 18F‐Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID‐19 Vaccination",

abstract = "In the following report, we describe 11 patients with various diagnoses and different treatment statuses (newly diagnosed, receiving treatment, or follow‐up) of oncological diseases (breast, lymphoma, melanoma, and head and neck cancers). The patients underwent PET‐CT for disease staging or follow‐up and it was noted that all patients had areas of hypermetabolic uptake in the axillary lymph‐nodes of the ipsilateral upper extremity where the Pfizer‐BioNTech coronavirus (COVID‐19) vaccine was administered. Following further investigations, including an ultrasound (US), biopsies and an examination of medical records, it was concluded that these findings were the result of the vaccination and not a progression of pre‐existing disease.",

keywords = "COVID‐19, Coronavirus, Hypermetabolic uptake, Oncology, PET‐CT, Vaccine",

author = "Walid Shalata and Daniel Levin and Janna Fridman and Victoria Makarov and Muhammed Iraqi and Mitchell Golosky and Keren Rouvinov and Waleed Kian and Alexander Yakobson",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors.",

year = "2022",

month = feb,

day = "1",

doi = "10.3390/curroncol29020084",

language = "English",

volume = "29",

pages = "989--1000",

journal = "Current Oncology",

issn = "1198-0052",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "2",

}

TY - JOUR

T1 - Metabolic Activity Assessment by 18F‐Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID‐19 Vaccination

AU - Shalata, Walid

AU - Levin, Daniel

AU - Fridman, Janna

AU - Makarov, Victoria

AU - Iraqi, Muhammed

AU - Golosky, Mitchell

AU - Rouvinov, Keren

AU - Kian, Waleed

AU - Yakobson, Alexander

PY - 2022/2/1

Y1 - 2022/2/1

N2 - In the following report, we describe 11 patients with various diagnoses and different treatment statuses (newly diagnosed, receiving treatment, or follow‐up) of oncological diseases (breast, lymphoma, melanoma, and head and neck cancers). The patients underwent PET‐CT for disease staging or follow‐up and it was noted that all patients had areas of hypermetabolic uptake in the axillary lymph‐nodes of the ipsilateral upper extremity where the Pfizer‐BioNTech coronavirus (COVID‐19) vaccine was administered. Following further investigations, including an ultrasound (US), biopsies and an examination of medical records, it was concluded that these findings were the result of the vaccination and not a progression of pre‐existing disease.

AB - In the following report, we describe 11 patients with various diagnoses and different treatment statuses (newly diagnosed, receiving treatment, or follow‐up) of oncological diseases (breast, lymphoma, melanoma, and head and neck cancers). The patients underwent PET‐CT for disease staging or follow‐up and it was noted that all patients had areas of hypermetabolic uptake in the axillary lymph‐nodes of the ipsilateral upper extremity where the Pfizer‐BioNTech coronavirus (COVID‐19) vaccine was administered. Following further investigations, including an ultrasound (US), biopsies and an examination of medical records, it was concluded that these findings were the result of the vaccination and not a progression of pre‐existing disease.

KW - COVID‐19

KW - Coronavirus

KW - Hypermetabolic uptake

KW - Oncology

KW - PET‐CT

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85124663621&partnerID=8YFLogxK

U2 - 10.3390/curroncol29020084

DO - 10.3390/curroncol29020084

M3 - Article

C2 - 35200583

AN - SCOPUS:85124663621

SN - 1198-0052

VL - 29

SP - 989

EP - 1000

JO - Current Oncology

JF - Current Oncology

IS - 2

ER -

Metabolic Activity Assessment by 18F‐Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID‐19 Vaccination

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this